The FDA said that broader use of Cephalon Inc.'s narcotic pain drug Fentora (fentanyl buccal tablet) could lead to widespread abuse and misuse, with potentially fatal outcomes. (BioWorld Today)

With the U.S. dealing with a slumping economy, which some have already declared a recession, venture capitalists and other investors in the life sciences industry might be less willing to take risks, said Donald Elmer, managing partner of Seattle-based Pacific Horizon Ventures. (BioWorld Financial Watch)